Dennis Slamon

Dennis Slamon, MD, PhD

UCLA Medical Center

Key Note Presenter

Financial Disclosure

Novartis

Consultant

Speaker

Grant Or Contract

Ownership Interest

Pfizer

Consultant

Speaker

TORL BioTherapeutics

Executive Role

1200 Pharma

Executive Role

Ownership Interest

Pfizer

Grant Or Contract

Ownership Interest

BioMarin (ended May 2024)

Executive Role

BioMarin

Ownership Interest

Amgen

Ownership Interest

TORL BioTherapeutics

Ownership Interest

Seattle Genetics

Ownership Interest